Artificiële Intelligentie helpt huisartsen longziekten opsporen
One year ago ArtiQ was announced as one of the 38 organizations to receive funding following a successful application in the latest round of the Artificial Intelligence in Health and Care Award. One year later we give you an update on the current advancements.
Boehringer Ingelheim and ArtiQ join forces to help bring specialist-level expertise to all levels of care.
ArtiQ presented at the International Respiratory Summit at the EXPO 2020.
ArtiQ announces a partnership with Vyaire Medical to bring its ArtiQ.PFT software to hospitals across Europe.
ArtiQ obtains ISO 13485 and CE marking (MDR) certification.
ArtiQ awarded a € 450 000 grant from VLAIO
Diagnosis of Interstitial Lung Disease (ILD) - Interview with professor Wim Wuyts
Watch the presentation below to get an overview of the latest applications of AI in respiratory medicine and to learn how doctors and AI can work together as a complimentary team.
ArtiQ in Artsenkrant.
ArtiQ, a KU Leuven spin-off company which helps doctors diagnose, treat and monitor respiratory problems, announces that it has successfully concluded its seed financing round, raising € 1 million euro. The financing will be used to launch ArtiQ|PFT, a decision support tool that offers pulmonologists a fast, reliable and standardized evaluation of a patient’s lung function.